Furthermore, NAFLD for lymphocyte and CD3+ counts, CVD for CD3+CD4+ and CD3+CD8+ percentage, DM for CD3+CD8+ percentage, and cancer for CD3+ percentage were all shown to be risk factors. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.